-
Je něco špatně v tomto záznamu ?
Recurrent EWSR1::COLCA2 Fusions Define a Novel Sarcoma With Spindle/Round Cell Morphology and Strong Predilection for the Sinonasal Tract
A. Agaimy, M. Baněčková, J. De Almeida, BC. Dickson, A. Dimmler, W. Hartmann, M. Laé, J. Pablik, C. Schubart, A. Skálová, R. Stoehr, M. Trautmann, E. Wardelmann, M. Wassef, I. Weinreb
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
- MeSH
- dospělí MeSH
- Ewingův sarkom * genetika MeSH
- fúzní onkogenní proteiny genetika MeSH
- hybridizace in situ fluorescenční MeSH
- kolorektální nádory * MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- nádorové biomarkery genetika MeSH
- nádorové proteiny genetika MeSH
- nádory měkkých tkání * MeSH
- nádory vedlejších dutin nosních * MeSH
- paranazální dutiny * patologie MeSH
- protein EWS vázající RNA genetika MeSH
- sarkom * genetika MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
The last 2 decades have attended a dynamic evolution in the nosology of poorly differentiated sinonasal tract malignancies, with several new molecularly defined entities having been described in addition to delineation of the genetic driver/s of some established older entities. These discoveries, however, mostly concerned epithelial-derived neoplasms (carcinomas). Adamantinoma-like Ewing sarcoma and biphenotypic sinonasal sarcoma are the major representatives of the newly defined mesenchymal categories. The colorectal cancer associated 2 (COLCA2) has been discovered recently as a colorectal cancer risk gene locus, but fusions involving this gene have not been well characterized. We, herein, describe clinicopathologic and molecular features of a novel sinonasal sarcoma characterized by undifferentiated spindle/round cell morphology and defined by recurrent EWSR1::COLCA2 fusions. All patients (n=5) were adults (3 female and 2 male) with a median age of 46 years (range, 23 to 60 y). The tumors originated in different subsites of the sinonasal tract with frequent multisite involvement. Original diagnoses were undifferentiated or unclassified round cell/spindle cell neoplasm/sarcoma (n=4) and neuroendocrine carcinoma (n=1). Surgery with or without adjuvant chemoradiation was the treatment in all cases. At the last follow-up, 1 patient developed multiple local recurrences over 21 years and another developed local recurrence and distant metastasis to bone 27 months after diagnosis. A third patient developed local recurrence 11 months later. Two patients were disease-free at 23, and 24 months. Histology showed nondescript highly cellular neoplasms with an admixture of spindled and round cells disposed into solid sheets and fascicles with brisk mitotic activity. Immunohistochemistry was negative for all lineage-specific markers with only limited focal membranous CD99 (4 of 5 cases) and weak pankeratin (1 of 5 cases) expression. Targeted RNA sequencing revealed an EWSR1::COLCA2 fusion, verified by EWSR1 fluorescence in situ hybridization, in all cases. This series identifies a novel member in the undifferentiated spindle/round cell sarcoma category with strong predilection for the sinonasal tract. None of >10,000 epithelial and mesenchymal neoplasms tested at the authors' centers during the same period showed this fusion, highlighting rarity of tumors carrying this gene fusion. Accordingly, molecular testing of unclassified sinonasal malignancies/sarcomas showing round and spindle cell morphology is recommended to enhance the identification and further characterization of this entity.
Bioptic Laboratory Ltd Plzen Czech Republic
Department of Otolaryngology Head and Neck Surgery Princess Margaret Hospital University of Toronto
Department of Pathobiology and Laboratory Medicine University of Toronto
Department of Pathology and Laboratory Medicine Mount Sinai Hospital
Department of Pathology Centre Henri Becquerel INSERM U1245 Université Rouen Normandie Rouen
Department of Pathology Charles University Faculty of Medicine in Plzen
Department of Pathology Hôpital Lariboisière Paris France
Department of Pathology University Hospital Dresden Dresden Germany
Gerhard Domagk Institute of Pathology Münster University Hospital
Institut und Gemeinschaftspraxis für Pathologie ViDia Christliche Kliniken Karlsruhe Karlsruhe
Laboratory Medicine Program University Health Network Toronto General Hospital Toronto ON Canada
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc23003992
- 003
- CZ-PrNML
- 005
- 20230425141025.0
- 007
- ta
- 008
- 230418s2023 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1097/PAS.0000000000002000 $2 doi
- 035 __
- $a (PubMed)36580038
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Agaimy, Abbas $u Institute of Pathology, Erlangen University Hospital, Comprehensive Cancer Center, European Metropolitan Area Erlangen-Nuremberg (CCC ER-EMN), Friedrich Alexander University of Erlangen-Nuremberg, Erlangen $1 https://orcid.org/0000000204458161
- 245 10
- $a Recurrent EWSR1::COLCA2 Fusions Define a Novel Sarcoma With Spindle/Round Cell Morphology and Strong Predilection for the Sinonasal Tract / $c A. Agaimy, M. Baněčková, J. De Almeida, BC. Dickson, A. Dimmler, W. Hartmann, M. Laé, J. Pablik, C. Schubart, A. Skálová, R. Stoehr, M. Trautmann, E. Wardelmann, M. Wassef, I. Weinreb
- 520 9_
- $a The last 2 decades have attended a dynamic evolution in the nosology of poorly differentiated sinonasal tract malignancies, with several new molecularly defined entities having been described in addition to delineation of the genetic driver/s of some established older entities. These discoveries, however, mostly concerned epithelial-derived neoplasms (carcinomas). Adamantinoma-like Ewing sarcoma and biphenotypic sinonasal sarcoma are the major representatives of the newly defined mesenchymal categories. The colorectal cancer associated 2 (COLCA2) has been discovered recently as a colorectal cancer risk gene locus, but fusions involving this gene have not been well characterized. We, herein, describe clinicopathologic and molecular features of a novel sinonasal sarcoma characterized by undifferentiated spindle/round cell morphology and defined by recurrent EWSR1::COLCA2 fusions. All patients (n=5) were adults (3 female and 2 male) with a median age of 46 years (range, 23 to 60 y). The tumors originated in different subsites of the sinonasal tract with frequent multisite involvement. Original diagnoses were undifferentiated or unclassified round cell/spindle cell neoplasm/sarcoma (n=4) and neuroendocrine carcinoma (n=1). Surgery with or without adjuvant chemoradiation was the treatment in all cases. At the last follow-up, 1 patient developed multiple local recurrences over 21 years and another developed local recurrence and distant metastasis to bone 27 months after diagnosis. A third patient developed local recurrence 11 months later. Two patients were disease-free at 23, and 24 months. Histology showed nondescript highly cellular neoplasms with an admixture of spindled and round cells disposed into solid sheets and fascicles with brisk mitotic activity. Immunohistochemistry was negative for all lineage-specific markers with only limited focal membranous CD99 (4 of 5 cases) and weak pankeratin (1 of 5 cases) expression. Targeted RNA sequencing revealed an EWSR1::COLCA2 fusion, verified by EWSR1 fluorescence in situ hybridization, in all cases. This series identifies a novel member in the undifferentiated spindle/round cell sarcoma category with strong predilection for the sinonasal tract. None of >10,000 epithelial and mesenchymal neoplasms tested at the authors' centers during the same period showed this fusion, highlighting rarity of tumors carrying this gene fusion. Accordingly, molecular testing of unclassified sinonasal malignancies/sarcomas showing round and spindle cell morphology is recommended to enhance the identification and further characterization of this entity.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a mladý dospělý $7 D055815
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a hybridizace in situ fluorescenční $7 D017404
- 650 12
- $a sarkom $x genetika $7 D012509
- 650 12
- $a Ewingův sarkom $x genetika $7 D012512
- 650 12
- $a nádory měkkých tkání $7 D012983
- 650 12
- $a nádory vedlejších dutin nosních $7 D010255
- 650 12
- $a paranazální dutiny $x patologie $7 D010256
- 650 12
- $a kolorektální nádory $7 D015179
- 650 _2
- $a nádorové biomarkery $x genetika $7 D014408
- 650 _2
- $a fúzní onkogenní proteiny $x genetika $7 D015514
- 650 _2
- $a protein EWS vázající RNA $x genetika $7 D034802
- 650 _2
- $a nádorové proteiny $x genetika $7 D009363
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Baněčková, Martina $u Department of Pathology, Charles University, Faculty of Medicine in Plzen $u Bioptic Laboratory Ltd, Plzen, Czech Republic
- 700 1_
- $a De Almeida, John $u Department of Otolaryngology, Head and Neck Surgery, Princess Margaret Hospital, University of Toronto
- 700 1_
- $a Dickson, Brendan C $u Department of Pathology & Laboratory Medicine, Mount Sinai Hospital $u Department of Pathobiology and Laboratory Medicine, University of Toronto
- 700 1_
- $a Dimmler, Arno $u Institut und Gemeinschaftspraxis für Pathologie, ViDia Christliche Kliniken Karlsruhe, Karlsruhe
- 700 1_
- $a Hartmann, Wolfgang $u Gerhard-Domagk-Institute of Pathology, Münster University Hospital $u Division of Translational Pathology, Gerhard-Domagk-Institute of Pathology, Münster University Hospital, Münster
- 700 1_
- $a Laé, Marick $u Department of Pathology, Centre Henri Becquerel, INSERM U1245, Université Rouen Normandie, Rouen
- 700 1_
- $a Pablik, Jessica $u Department of Pathology, University Hospital Dresden, Dresden, Germany
- 700 1_
- $a Schubart, Christoph $u Institute of Pathology, Erlangen University Hospital, Comprehensive Cancer Center, European Metropolitan Area Erlangen-Nuremberg (CCC ER-EMN), Friedrich Alexander University of Erlangen-Nuremberg, Erlangen
- 700 1_
- $a Skálová, Alena $u Department of Pathology, Charles University, Faculty of Medicine in Plzen $u Bioptic Laboratory Ltd, Plzen, Czech Republic
- 700 1_
- $a Stoehr, Robert $u Institute of Pathology, Erlangen University Hospital, Comprehensive Cancer Center, European Metropolitan Area Erlangen-Nuremberg (CCC ER-EMN), Friedrich Alexander University of Erlangen-Nuremberg, Erlangen
- 700 1_
- $a Trautmann, Marcel $u Gerhard-Domagk-Institute of Pathology, Münster University Hospital $u Division of Translational Pathology, Gerhard-Domagk-Institute of Pathology, Münster University Hospital, Münster
- 700 1_
- $a Wardelmann, Eva $u Gerhard-Domagk-Institute of Pathology, Münster University Hospital
- 700 1_
- $a Wassef, Michel $u Department of Pathology, Hôpital Lariboisière, Paris, France
- 700 1_
- $a Weinreb, Ilan $u Laboratory Medicine Program, University Health Network, Toronto General Hospital, Toronto, ON, Canada
- 773 0_
- $w MED00000304 $t The American journal of surgical pathology $x 1532-0979 $g Roč. 47, č. 3 (2023), s. 361-369
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/36580038 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20230418 $b ABA008
- 991 __
- $a 20230425141022 $b ABA008
- 999 __
- $a ok $b bmc $g 1924570 $s 1190201
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2023 $b 47 $c 3 $d 361-369 $e 20221114 $i 1532-0979 $m The American journal of surgical pathology $n Am J Surg Pathol $x MED00000304
- LZP __
- $a Pubmed-20230418